Cypress Capital Management (Delaware)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $8.92M | Sell |
|
|||||
|
2022
Q2 | $10.8M | Sell |
|
|||||
|
2022
Q1 | $10.7M | Sell |
|
|||||
|
2021
Q4 | $12.2M | Buy |
|
|||||
|
2021
Q3 | $7.77M | Hold |
|
|||||
|
2021
Q2 | $7.77M | Buy |
|
|||||
|
2021
Q1 | $7.01M | Buy |
|
|||||
|
2020
Q4 | $824K | Sell |
|
|||||
|
2020
Q3 | $939K | Buy |
|
|||||
|
2020
Q2 | $814K | Hold |
|
|||||
|
2020
Q1 | $812K | Sell |
|
|||||
|
2019
Q4 | $12.8M | Sell |
|
|||||
|
2019
Q3 | $11.9M | Buy |
|
|||||
|
2019
Q2 | $14M | Buy |
|
|||||
|
2019
Q1 | $13.4M | Sell |
|
|||||
|
2018
Q4 | $18.2M | Sell |
|
|||||
|
2018
Q3 | $18.7M | Sell |
|
|||||
|
2018
Q2 | $15.5M | Buy |
|
|||||
|
2018
Q1 | $15.1M | Sell |
|
|||||
|
2017
Q4 | $15.6M | Buy |
|
|||||
|
2017
Q3 | $15.3M | Buy |
|
|||||
|
2017
Q2 | $14.2M | Buy |
|
|||||
|
2017
Q1 | $14.4M | Buy |
|
|||||
|
2016
Q4 | $13.5M | Buy |
|
|||||
|
2016
Q3 | $13.8M | Sell |
|
|||||
|
2016
Q2 | $14.4M | Sell |
|
|||||
|
2016
Q1 | $12.2M | Buy |
|
|||||
|
2015
Q4 | $13.2M | Sell |
|
|||||
|
2015
Q3 | $13M | Sell |
|
|||||
|
2015
Q2 | $13.8M | Sell |
|
|||||
|
2015
Q1 | $14.4M | Sell |
|
|||||
|
2014
Q4 | $13.2M | Sell |
|
|||||
|
2014
Q3 | $12.8M | Buy |
|
|||||
|
2014
Q2 | $12.8M | Sell |
|
|||||
|
2014
Q1 | $14.1M | Buy |
|
|||||
|
2013
Q4 | $13.4M | Sell |
|
|||||
|
2013
Q3 | $12.7M | Sell |
|
|||||
|
2013
Q2 | $13M | Buy |
|